Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuraxis (NRXS) Net Income towards Common Stockholders (2022 - 2025)

Historic Net Income towards Common Stockholders for Neuraxis (NRXS) over the last 4 years, with Q3 2025 value amounting to -$2.3 million.

  • Neuraxis' Net Income towards Common Stockholders fell 2896.85% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.3 million, marking a year-over-year increase of 3148.32%. This contributed to the annual value of -$8.5 million for FY2024, which is 4220.99% up from last year.
  • Latest data reveals that Neuraxis reported Net Income towards Common Stockholders of -$2.3 million as of Q3 2025, which was down 2896.85% from -$1.9 million recorded in Q2 2025.
  • In the past 5 years, Neuraxis' Net Income towards Common Stockholders ranged from a high of -$206423.0 in Q4 2022 and a low of -$5.3 million during Q4 2023
  • For the 4-year period, Neuraxis' Net Income towards Common Stockholders averaged around -$2.4 million, with its median value being -$2.2 million (2022).
  • As far as peak fluctuations go, Neuraxis' Net Income towards Common Stockholders tumbled by 247398.88% in 2023, and later soared by 6961.68% in 2024.
  • Quarter analysis of 4 years shows Neuraxis' Net Income towards Common Stockholders stood at -$206423.0 in 2022, then plummeted by 2473.99% to -$5.3 million in 2023, then surged by 69.62% to -$1.6 million in 2024, then tumbled by 43.8% to -$2.3 million in 2025.
  • Its Net Income towards Common Stockholders was -$2.3 million in Q3 2025, compared to -$1.9 million in Q2 2025 and -$2.5 million in Q1 2025.